Johnson & Johnson submits sNDA to FDA for Caplyta

Tuesday, Jul 8, 2025 8:03 am ET1min read
JNJ--

Johnson & Johnson submits sNDA to FDA for Caplyta

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet